Now showing items 1-3 of 3
Current Practice In Identifying And Treating Cardiovascular Risk, With A Focus On Residual Risk Associated With Atherogenic Dyslipidaemia
(Oxford Univ Press, 2016)
A panel of European experts on lipids and cardiovascular disease discussed clinical approaches to managing cardiovascular risk in clinical practice, including residual cardiovascular risk associated with lipid abnormalities, ...
Prevalence of Potential Familial Hypercholesteremia (Fh) in 54,811 Statin-Treated Patients in Clinical Practice
(Elsevier Ireland Ltd, 2016)
Background and aims: Familial hypercholesterolemia (FH) is a life-threatening disease, characterized by elevated LDL-C levels and a premature, increased risk of coronary heart disease (CHD) that is globally underdiagnosed. ...